Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Operations (Unaudited)

v3.23.1
Condensed Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues $ 15,087,000 $ 13,177,000 $ 50,085,000 $ 27,138,000
Cost of sales 10,368,000 11,257,000 37,310,000 22,838,000
Gross profit 4,719,000 1,920,000 12,775,000 4,300,000
Operating expenses:        
Selling and administrative 4,724,000 3,904,000 13,510,000 11,402,000
Research and development 1,182,000 1,713,000 3,567,000 5,768,000
Total operating expenses 5,906,000 5,617,000 17,077,000 17,170,000
Operating loss (1,187,000) (3,697,000) (4,302,000) (12,870,000)
Other income 8,000
Interest expense (258,000) (52,000) (971,000) (86,000)
Net loss $ (1,445,000) $ (3,749,000) $ (5,265,000) $ (12,956,000)
Net loss per share - basic and diluted $ (0.09) $ (0.23) $ (0.33) $ (0.85)
Weighted average number of common shares outstanding - basic and diluted 16,048,054 15,988,926 16,021,653 15,254,983